Literature DB >> 31168601

OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer.

T Y Seiwert, C C Foster, E A Blair, T G Karrison, N Agrawal, J M Melotek, L Portugal, R J Brisson, A Dekker, S Kochanny, Z Gooi, M W Lingen, V M Villaflor, D T Ginat, D J Haraf, E E Vokes.   

Abstract

Entities:  

Year:  2019        PMID： 31168601     DOI： 10.1093/annonc/mdz171

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  11 in total

1.  Association of human papillomavirus integration with better patient outcomes in oropharyngeal squamous cell carcinoma.

Authors:  Lisa M Pinatti; Hana N Sinha; Collin V Brummel; Christine M Goudsmit; Timothy J Geddes; George D Wilson; Jan A Akervall; Chad J Brenner; Heather M Walline; Thomas E Carey
Journal:  Head Neck       Date:  2020-10-19       Impact factor: 3.147

2.  De-Escalated Adjuvant Therapy After Transoral Robotic Surgery for Human Papillomavirus-Related Oropharyngeal Carcinoma: The Sinai Robotic Surgery (SIRS) Trial.

Authors:  Brett A Miles; Marshall R Posner; Vishal Gupta; Marita S Teng; Richard L Bakst; Mike Yao; Kryzsztof J Misiukiewicz; Raymond L Chai; Sonam Sharma; William H Westra; Seunghee Kim-Schulze; Bheesham Dayal; Stanislaw Sobotka; Andrew G Sikora; Peter M Som; Eric M Genden
Journal:  Oncologist       Date:  2021-03-18

3.  Phase I study of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinoma.

Authors:  Ari J Rosenberg; Nishant Agrawal; Alexander T Pearson; Zhen Gooi; Elizabeth Blair; Louis Portugal; John F Cursio; Aditya Juloori; Jeffrey Chin; Kathryn Rouse; Victoria M Villaflor; Tanguy Y Seiwert; Evgeny Izumchenko; Mark W Lingen; Daniel J Haraf; Everett E Vokes
Journal:  Br J Cancer       Date:  2022-08-09       Impact factor: 9.075

4.  Tumor Volume Reduction Rate to Induction Chemotherapy is a Prognostic Factor for Locally Advanced Head and Neck Squamous Cell Carcinoma: A Retrospective Cohort Study.

Authors:  Ting-Chun Lin; Chi-Hsien Huang; Ming-Yu Lien; Fu-Ming Cheng; Kai-Chiun Li; Chih-Yuan Lin; Ying-Chun Lin; Ji-An Liang; Ti-Hao Wang
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

5.  Risk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experience.

Authors:  Ari J Rosenberg; Nishant Agrawal; Alexander Pearson; Zhen Gooi; Elizabeth Blair; John Cursio; Aditya Juloori; Daniel Ginat; Adam Howard; Jeffrey Chin; Sara Kochanny; Corey Foster; Nicole Cipriani; Mark Lingen; Evgeny Izumchenko; Tanguy Y Seiwert; Daniel Haraf; Everett E Vokes
Journal:  Oral Oncol       Date:  2021-10-18       Impact factor: 5.972

6.  Hypoxia-Guided Therapy for Human Papillomavirus-Associated Oropharynx Cancer.

Authors:  Barbara Burtness; Joseph Contessa
Journal:  J Natl Cancer Inst       Date:  2021-06-01       Impact factor: 13.506

Review 7.  Application of liquid biopsy as multi-functional biomarkers in head and neck cancer.

Authors:  Vasudha Mishra; Alka Singh; Xiangying Chen; Ari J Rosenberg; Alexander T Pearson; Alex Zhavoronkov; Peter A Savage; Mark W Lingen; Nishant Agrawal; Evgeny Izumchenko
Journal:  Br J Cancer       Date:  2021-12-07       Impact factor: 7.640

Review 8.  Beyond MicroRNAs: Emerging Role of Other Non-Coding RNAs in HPV-Driven Cancers.

Authors:  Mariateresa Casarotto; Giuseppe Fanetti; Roberto Guerrieri; Elisa Palazzari; Valentina Lupato; Agostino Steffan; Jerry Polesel; Paolo Boscolo-Rizzo; Elisabetta Fratta
Journal:  Cancers (Basel)       Date:  2020-05-15       Impact factor: 6.639

Review 9.  Special Issue about Head and Neck Cancers: HPV Positive Cancers.

Authors:  Panagiota Economopoulou; Ioannis Kotsantis; Amanda Psyrri
Journal:  Int J Mol Sci       Date:  2020-05-11       Impact factor: 5.923

10.  Definitive chemoradiotherapy in patients with squamous cell cancers of the head and neck - results from an unselected cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".

Authors:  Lars Schüttrumpf; Sebastian Marschner; Katrin Scheu; Julia Hess; Sibylle Rietzler; Axel Walch; Philipp Baumeister; Thomas Kirchner; Ute Ganswindt; Horst Zitzelsberger; Claus Belka; Cornelius Maihoefer
Journal:  Radiat Oncol       Date:  2020-01-06       Impact factor: 3.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.